Lazurite® Names Julia Greenspan Director of Sales Operations

CLEVELAND, September 6, 2023–(BUSINESS WIRE)–Medical device and technology company Lazurite® has named Julia Greenspan Director of Sales Operations. In this position, she is responsible for leading sales operations, including the sales process and funnel management, sales support and training, and customer training on use and maintenance of the ArthroFree® Surgical Camera System, the first FDA-cleared wireless surgical camera for arthroscopy and general endoscopy.

Greenspan has spent the last 25 years in the operating room/medical device industry in roles of increasing responsibility, from surgical technologist to senior orthopedic trauma sales representative and regional director of medical education. She has worked for leading orthopedic device companies Stryker Orthopedics and DepuySynthes Trauma, as well as 3M Healthcare. In addition to her professional commitments, she remains actively involved in volunteer work for Operation Rainbow, where she works two medical missions per year to provide orthopedic surgical care for patients in underserved communities within South America.

Greenspan has an MBA (STEM) and a Bachelor of Arts in Psychology from the University of California, Davis. She also has an executive coaching certificate from the University of California, Berkeley, and Lean Six Sigma Blackbelt certification.

“We are delighted to have Julia on the Lazurite team,” Lazurite President Leah Brownlee said. “Her extensive experience in medical products sales and education, particularly in orthopedics, will bolster customer support and satisfaction as facilities across the country adopt the ArthroFree® Wireless Camera System.

“The ArthroFree System has been used in hundreds of cases at facilities around the country, including NYU Langone; University Hospitals in Cleveland; De La Vina Surgicenter in Santa Barbara; Baylor Scott & White Medical Center in Frisco, Texas; and the New York Sports Medicine Institute,” she said.

About Lazurite

Lazurite designs medtech devices, and its ArthroFree® System is the first wireless camera with FDA clearance for arthroscopy and general endoscopy. It eliminates the camera cables associated with patient burns and fires, and it’s drop-in compatible with current OR technologies. The ArthroFree wireless camera also allows untethered movement by surgeons and projects cost-per-case savings. Lazurite’s IP portfolio also includes the high-efficiency Meridiem® light technology, wireless communication technology, and products in development. Lazurite is located in Cleveland, OH (est. 2015), and has raised more than $30M from institutional investors, family offices, and more than 70 physician champions. Our three-year vision (by 2026): Modernize 1,000 operating rooms for the wireless age. For more information, see

Forward-Looking Statements

This press release includes “forward-looking statements.” Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “projected,” “estimate,” “expect,” “may,” “should,” “will,” “designed,” “optimistic,” “shows promise”, “allows” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the expected impact and ease of use advantages of the ArthroFree System within the field of minimally invasive surgery, particularly orthopedic surgery. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Lazurite®, ArthroFree®, and Meridiem® are registered trademarks of Lazurite Holdings LLC.

Media Center

Visit videos, logos, images, fact sheets, bios and more.


Patrick Gallagher
+1 (216) 233-7473

+1 (833) 214-4234

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button